Fidelity Investments
TNXP icon

Fidelity Investments’s Tonix Pharmaceuticals TNXP Stock Holding History

Fidelity Investments’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
93,551
+91,813
+5,283% +$1.18M ﹤0.01% 2935
2026
Q1 		$23.9K Buy
1,738
+234
+16% +$3.6K ﹤0.01% 4443
2025
Q4 		$23.5K Sell
1,504
-43,962
-97% -$810K ﹤0.01% 4406
2025
Q3 		$1.1M Buy
45,466
+32,713
+257% +$1.21M ﹤0.01% 2766
2025
Q2 		$459K Buy
+12,753
New +$334K ﹤0.01% 2992
2025
Q1 		– Hold
0
– – – 5671
2024
Q4 		– Hold
0
– – – 5809
2024
Q3 		– Hold
0
– – – 5727
2024
Q1 		– Hold
0
– -$10 – 5714
2023
Q4 		– Hold
0
– – – 5325
2023
Q3 		– Hold
0
– – – 5240
2023
Q1 		– Hold
0
– – – 5521
2022
Q4 		– Hold
0
– – – 5593
2022
Q3 		– Hold
0
– -$3K – 5401
2022
Q2 		– Hold
0
– – – 4496
2022
Q1 		– Hold
0
– – – 4453
2021
Q4 		– Hold
0
– – – 4920
2021
Q3 		– Hold
0
– – – 5021
2021
Q2 		– Hold
0
– – – 4870

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments's TNXP Position: Q2 2026 in Review

Fidelity Investments increased its Tonix Pharmaceuticals (TNXP) stake by 5,283% in Q2 2026, buying an estimated $1.18M and bringing the position to 93,551 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2935.

Fidelity Investments first reported a position in TNXP in Q2 2025 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Fidelity Investments held 93,551 shares of Tonix Pharmaceuticals worth $1.19M as of Q2 2026.
  • Fidelity Investments bought 91,813 Tonix Pharmaceuticals shares in Q2 2026, an estimated $1.18M.
  • Tonix Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2935 holding.
  • Fidelity Investments first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.